Closed · RFA-TR-17-007 · CFDA 93.350 · Discretionary
NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $400K
- Award range
- Closed
- Status
- April 14, 2017
- Close date
- -
- Expected awards
The verdict
NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18) is a closed discretionary listing from National Institutes of Health that offered Up to $400,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $400K
- award range
- Closed
- application status
- 93.350
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
NCATS Pilot Program for Collaborative Drug Di… is closed (last close April 14, 2017). The parent program page for CFDA 93.350 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed April 14, 2017
Est. Total Funding
$3,000,000
Instrument
Cooperative Agreement
Description
The goal of this Funding Opportunity Announcement (FOA) is to enable the development of 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at the National Center for Advancing Translational Sciences (NCATS) and extramural scientists. NCATS intramural scientists will provide expertise for 3-D bioprinting, assay development and drug screening stages of the projects. Extramural investigators will provide appropriate cell resources, disease expertise and model validation in collaboration with NCATS to perform drug screening of bioprinted materials. The research application will involve 3-D bioprinting in a screening format of patient-derived cells supplied by the extramural investigators, characterization and validation of bioprinted materials by NCATS investigators and extramural collaborators, and screening of appropriate molecular libraries.
Wide-open applicant board · 15 Grants.gov doors
NCATS Pilot Program for Collaborative Drug Di… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the National Institutes of Health book (9,741 peers, 78% of 12,420).
- Code 00
- State governments
- Code 01
- County governments
- Code 02
- City or township governments
- Code 04
- Special district governments
- Code 05
- Independent school districts
- Code 06
- Public / state-controlled institutions of higher education
- Code 07
- Federally recognized tribal governments
- Code 08
- Public / Indian housing authorities
- Code 11
- Native American tribal organizations (other than Federally recognized tribal governments)
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 23
- Small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Mental Health National Research Service Awards
National Institutes of Health
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
NCATS Pilot Program for Collaborative Drug Di… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.350 may publish future NOFOs under the same assistance listing. Open program
- Mental Health National Research Service Awards indexes 26 Grants.gov listings in this extract. Program profile
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |